Replies to post #588121 on NorthWest Biotherapeutics Inc (NWBO)

[The Danish Dude]

DCVax-L's dubious P3 trial has to stand on it's own

Woops!

Seems as if it does and all your confounded worries are all on your behalf.

FDA and MHRA have removed all obstacles in that regard.

$NWBO

45 approvals id'ed where FDA accepted ext. control data in benefit/risk assessment; doing so for many reasons incl. rare nature of the disease, ethical concerns wrt use ofplacebo or no-treatment arm, seriousness of condition, and unmet medical needhttps://t.co/g0GotzwuwH pic.twitter.com/HMJwXD4Q78

— 🇩🇰 The Danish Dude 🇩🇰 (@FlemmingBruce) April 19, 2023

[Roman516]

Once again, this is not true at all regarding the application, and again this has nothing to do with my previous posts in response to your posts. Either way, NWBO will prevail, and DCVax-L will be preferred over the electro cap, IMPO.

[Dr Bala]

HyGro, it would be interesting to post about the low glioma trials. I think the INDIGO trial and similar ones would be of interest.